TRENTON, N.J. (AP) — For Alzheimer's patients desperate for an effective treatment, several new studies starting up offer hope.
After dozens of promising experimental drugs failed, scientists think they're now on the right track, targeting the mechanisms to arrest the epidemic, mind-robbing disease.
Dr. William H. Thies, the Alzheimer's Association's top scientist, says if the new studies succeed, a medicine that slows or even stops progression of Alzheimer's might be ready in three to five years. That's only if tens of millions of dollars more are found for research and more patients join clinical studies.
Drugmakers including Merck & Co., Eli Lilly and Co. and the Roche Group are working on drugs that use different mechanisms to limit accumulation in the brain of the amyloid plaques considered the most likely cause of Alzheimer's.
After Youtube Terminated His Account Twice, Hickok45 Found A New Home
Mike Shedlock - European Bloodbath Spills Over to US Markets: Deutsche Bank CoCo Bonds Collapse, Shares at Record Low
Toxic Words | Human Events
Bill Clinton sometimes wishes he weren't married to Hillary
Final CNN tracking poll of NH: Trump leads big, Rubio second, Bush and Christie in deep trouble
Donald Trump Just Called Ted Cruz 'A P*ssy' [VIDEO] | RedState